Acorah Software Products - Accounts Production 16.5.460 false true 31 October 2024 1 November 2023 false 1 November 2024 31 October 2025 31 October 2025 11004134 Mr Ankit Thapar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11004134 2024-10-31 11004134 2025-10-31 11004134 2024-11-01 2025-10-31 11004134 frs-core:CurrentFinancialInstruments 2025-10-31 11004134 frs-core:Non-currentFinancialInstruments 2025-10-31 11004134 frs-core:ComputerEquipment 2025-10-31 11004134 frs-core:ComputerEquipment 2024-11-01 2025-10-31 11004134 frs-core:ComputerEquipment 2024-10-31 11004134 frs-core:FurnitureFittings 2025-10-31 11004134 frs-core:FurnitureFittings 2024-11-01 2025-10-31 11004134 frs-core:FurnitureFittings 2024-10-31 11004134 frs-core:ShareCapital 2025-10-31 11004134 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 11004134 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11004134 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 11004134 frs-bus:SmallEntities 2024-11-01 2025-10-31 11004134 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 11004134 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 11004134 frs-bus:Director1 2024-11-01 2025-10-31 11004134 frs-countries:EnglandWales 2024-11-01 2025-10-31 11004134 2023-10-31 11004134 2024-10-31 11004134 2023-11-01 2024-10-31 11004134 frs-core:CurrentFinancialInstruments 2024-10-31 11004134 frs-core:Non-currentFinancialInstruments 2024-10-31 11004134 frs-core:ShareCapital 2024-10-31 11004134 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31
Registered number: 11004134
Trojan Pharm Limited
Financial Statements
For The Year Ended 31 October 2025
Accountability PSM
Ballicom House
101 Lockhurst Lane
Coventry
CV6 5SF
Trojan Pharm Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
Trojan Pharm Limited
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 11004134

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | - |  | 4,330
|  |  | - |  | 4,330
CURRENT ASSETS
Stocks | 5 | - |  | 5,866 |
Debtors | 6 | 1,613 |  | 4,585 |
Cash at bank and in hand |  | 685 |  | 2,189 |
|  | 2,298 |  | 12,640 |
Creditors: Amounts Falling Due Within One Year | 7 | (10,751 ) |  | (10,877 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (8,453 ) |  | 1,763
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | (8,453 ) |  | 6,093
Creditors: Amounts Falling Due After More Than One Year | 8 |  | (45,739 ) |  | (49,244 )
NET LIABILITIES |  |  | (54,192 ) |  | (43,151 )
CAPITAL AND RESERVES
Called up share capital | 9 |  | 1 |  | 1
Profit and Loss Account |  |  | (54,193 ) |  | (43,152 )
SHAREHOLDERS' FUNDS |  |  | (54,192) |  | (43,151)

Page 1
Page 2
Trojan Pharm Limited
Balance Sheet (continued)
As At 31 October 2025
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Ankit Thapar Director
31 October 2025

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Trojan Pharm Limited
Notes to the Financial Statements
For The Year Ended 31 October 2025
Notes to the Financial Statements
1. General Information
Trojan Pharm Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11004134 . The registered office is 64 Burnaby Road, Coventry, CV6 4BB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings | 10% on reducing balance
Computer Equipment | 10% on reducingbalance

2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
Page 3
Page 4
Trojan Pharm Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
4. Tangible Assets

| Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 November 2024 | 1,100 | 7,047 | 8,147
Disposals | (585 ) | (3,745 ) | (4,330 )
As at 31 October 2025 | 515 | 3,302 | 3,817
Depreciation
As at 1 November 2024 | 515 | 3,302 | 3,817
As at 31 October 2025 | 515 | 3,302 | 3,817
Net Book Value
As at 31 October 2025 | - | - | -
As at 1 November 2024 | 585 | 3,745 | 4,330

5. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Stock | - |  | 5,866

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | - |  | 2,869
VAT | 1,613 |  | 1,716
| 1,613 |  | 4,585

7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 1 |  | 127
Family Loan | 10,000 |  | 10,000
Accruals and deferred income | 750 |  | 750
| 10,751 |  | 10,877

Page 4
Page 5
Trojan Pharm Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
8. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Directors loan account | 45,739 |  | 49,244

9. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 1 |  | 1

Page 5